ArticlePharmaceuticals (Basel, Switzerland)2026

Psychiatric Adverse Events and Administration Challenges Associated with GLP-1 Receptor Agonists for Weight Loss: A Real-World Analysis.

Ali Hindi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.